BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 5630870)

  • 1. Clinical and experimental studies on auricular fibrillation.
    Hibino S
    Jpn Circ J; 1967 Nov; 31(11):1523-31. PubMed ID: 5630870
    [No Abstract]   [Full Text] [Related]  

  • 2. [Favorable factors in electrocardioversion in atrial fibrillation].
    Serafim L; Iliescu CC
    Med Interna (Bucur); 1970 Jan; 22(1):69-74. PubMed ID: 5527976
    [No Abstract]   [Full Text] [Related]  

  • 3. [Late results following cardioversion].
    Enenkel W
    Wien Z Inn Med; 1967; 48(7):275-83. PubMed ID: 5620578
    [No Abstract]   [Full Text] [Related]  

  • 4. [Mechanism of the origin and maintenance of auricular fibrillation].
    Sano T
    Saishin Igaku; 1968 Jan; 23(1):10-20. PubMed ID: 5675723
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparative antiarrhythmic activity of beta-N-hexamethyleneimino-P-butoxypropiophenone, quinidine and novocaine amide in aconitine auricular fibrillation and flutter in cats].
    Ammar EM; Kudrin AN
    Farmakol Toksikol; 1969; 32(4):415-8. PubMed ID: 5357458
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of auricular flutter using endocavitary auricular stimulation].
    Puech P; Grolleau R; Latour H; Cabasson J; Robin JM; Baissus C
    Arch Mal Coeur Vaiss; 1973 Feb; 66(2):159-67. PubMed ID: 4201801
    [No Abstract]   [Full Text] [Related]  

  • 7. Early and late results of conversion of atrial fibrillation with quinidine. A clinical and hemodynamic study.
    Cramér G
    Acta Med Scand Suppl; 1968; 490():5-102. PubMed ID: 5253729
    [No Abstract]   [Full Text] [Related]  

  • 8. [The treatment of atrial fibrillation with polygalacturonate of quinidine administered with a special method].
    Fiori W; Civai O
    Atti Accad Fisiocrit Siena Med Fis; 1966; 15(2):838-52. PubMed ID: 6001554
    [No Abstract]   [Full Text] [Related]  

  • 9. Exercise testing of patients with coronary heart disease. Principles and normal standards for evaluation.
    Bruce RA
    Ann Clin Res; 1971 Dec; 3(6):323-32. PubMed ID: 5156892
    [No Abstract]   [Full Text] [Related]  

  • 10. [Study of the behavior of left ventricular systolic intervals in quinidine defibrillation].
    Ferrer Reig J; Peris Monfort M; Navarro Martínez L; Olagüe de Ros J; Algarra Vidal FJ
    Rev Esp Cardiol; 1972; 25(1):37-49. PubMed ID: 5038564
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hyperthyroidism and risk of atrial fibrillation or flutter--secondary publication. A population-based study].
    Frost L; Vestergaard P; Mosekilde L
    Ugeskr Laeger; 2005 Aug; 167(35):3305-7. PubMed ID: 16138975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Character of atrial fibrillation waves in thyrotoxicosis with cardiac involvement].
    Vána S; Nĕmec J; Valenta L
    Vnitr Lek; 1969 Nov; 15(11):1064-9. PubMed ID: 5364825
    [No Abstract]   [Full Text] [Related]  

  • 13. Normal and abnormal excitation of cardiac muscle fibers, especially fibrillation.
    Sano T
    Jpn Circ J; 1967 Nov; 31(11):1550-5. PubMed ID: 5630872
    [No Abstract]   [Full Text] [Related]  

  • 14. [Relations between hyperthyroidism and atrial fibrillation, with special reference to the diagnostic value of the amplitude of the "f" waves].
    Marazzini L; Rizzato F; Valentini F
    Minerva Cardioangiol; 1966 Nov; 14(11):644-50. PubMed ID: 5999110
    [No Abstract]   [Full Text] [Related]  

  • 15. Atrial fibrillation. I.
    Br Med J; 1971 Jul; 3(5768):239-41. PubMed ID: 5559046
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical factors that influence response to treatment strategies in atrial fibrillation: the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.
    Curtis AB; Gersh BJ; Corley SD; DiMarco JP; Domanski MJ; Geller N; Greene HL; Kellen JC; Mickel M; Nelson JD; Rosenberg Y; Schron E; Shemanski L; Waldo AL; Wyse DG;
    Am Heart J; 2005 Apr; 149(4):645-9. PubMed ID: 15990747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atrial fibrillation.
    Sloan RW
    Am Fam Physician; 1982 Jun; 25(6):165-71. PubMed ID: 6211071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of new-onset atrial fibrillation and its predictors with angiotensin II-receptor blockers in the treatment of hypertension and heart failure.
    Aksnes TA; Flaa A; Strand A; Kjeldsen SE
    J Hypertens; 2007 Jan; 25(1):15-23. PubMed ID: 17143167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Considerations on the etiology and treatment of complete arrhythmias (with reference to 250 patients treated with external electric shock)].
    Raynaud R; Brochier M; Raynaud P
    Med Interna (Bucur); 1968 Apr; 20(4):461-6. PubMed ID: 5735417
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pharmacologic combination of propranolol and quinidine in the treatment of atrial fibrillation: indications and early and long-term results].
    Levi GF; Proto C
    Policlinico Prat; 1969 Nov; 76(47):1513-20. PubMed ID: 5402628
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.